Latest Breaking News On - Sun pharmaceutical industrie - Page 1 : comparemela.com

Daily Markets: November CPI Brings Tea Leaves Ahead of the Fed

Daily Markets: November CPI Brings Tea Leaves Ahead of the Fed
nasdaq.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nasdaq.com Daily Mail and Mail on Sunday newspapers.

United kingdomPat gelsingerDenzel washingtonEnergy metalsEuropean central bank interest rate decisionJibun bank flash manufacturingGlobal payments incNasdaq incCommunications servicesOil inventoriesWalgreens boots allianceMoody investors serviceFenix groupInternational economyShanghai compositeSouth korea

sun pharma q1 results: Sun Pharma Q1 preview: Weak Taro show, soft US sales to weigh on earnings

Consolidated net profit is seen declining 1.4% YoY to Rs 2,033 crore. Indias largest pharmaceutical company by market capitalization is scheduled to release its earnings on Thursday.

Madhya pradeshSun pharmaCequa trxTaro pharmaceutical industriesSun pharmaceutical industrieDrug administrationSun pharma q1 resultsSun pharma q1 previewSun pharma q1Sun pharma share priceTaro pharmaSun pharmaceutical

Krensavage AMC opposes Sun Pharma s bid to delist Taro shares

Krensavage AMC opposes Sun Pharma s bid to delist Taro shares
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Sun pharmaKrensavage asset managementSun pharmaceutical industrieTaro pharmaceuticalTaro pharma

USFDA lists Sun Pharma s Halol unit under import alert , stock falls 2 5%

Sun Pharma update: The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's cGMP standards

Sun pharmaSun pharmaceutical industriesDrug administrationSun pharmaceutical industrieGood manufacturing practicePharmaceutical industriesAlol facilityPharma imports

Sun Pharma gains after licensing agreement with Ferring Pharma for Caritec in India

Sun Pharmaceutical Industries rose 1.01% to Rs 678 after the company said that it has entered into a license agreement with Ferring Pharmaceuticals to commercialize obstetric drug, Caritec in India.Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals (Ferring), a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialize a Room Temperature Stable (RTS) formulation of obstetric drug, Caritec (Carbetocin RTS) in India. Caritec is indicated for the prevention of excessive bleeding in women after vaginal or caesarean child birth. The condition is commonly known as post-partum hemorrhage (PPH). As per agreement terms, Sun Pharma is granted rights for co-marketing of the drugin India in the private market under the brand name Caritec. Ferring has developed the drug and received approval from the Drugs Controller General of India (DCGI) for introducing the

Sun pharmaSun pharmaceutical industriesFerring pharmaceuticalsIndia sun pharmaceutical industriesRoom temperature stableDrugs controller generalSun pharmaceutical industriePharmaceutical industriesCapital marketHealth carePharmaceutical companiesFerring pharmaceuticalsNifty 50Sun pharmaPharmaceutical industry in indiaPharmaceutical industry in china